Abacus Wealth Partners, LLC Amgen Inc Transaction History

Abacus Wealth Partners, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$262.75 - $319.31 $18,392 - $22,351	-70 Reduced 9.59%	660 $206 Million
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $2,419 - $2,921	-9 Reduced 1.22%	730 $208 Million
Q4 2023 Feb 07, 2024	SELL	$255.7 - $288.46 $32,985 - $37,211	-129 Reduced 14.86%	739 $213 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $189,788 - $235,627	868 New	868 $233 Million
Q1 2023 May 19, 2023	BUY	$225.79 - $275.2 $254,465 - $310,150	1,127 New	1,127 $267 Million
Q1 2022 May 31, 2023	SELL	$219.27 - $242.57 $607,597 - $672,161	-2,771 Closed	0 $0
Q4 2021 May 31, 2023	BUY	$198.88 - $227.6 $326,958 - $374,174	1,644 Added 145.87%	2,771 $623 Million
Q3 2021 May 31, 2023	SELL	$212.27 - $248.7 $6,368 - $7,461	-30 Reduced 3.03%	959 $204 Million
Q2 2021 May 31, 2023	SELL	$233.58 - $259.14 $32,234 - $35,761	-138 Reduced 12.24%	989 $241 Million
Q1 2021 May 31, 2023	SELL	$221.91 - $258.6 $21,747 - $25,342	-98 Reduced 9.38%	947 $236 Million
Q4 2020 May 31, 2023	SELL	$216.38 - $257.67 $17,743 - $21,128	-82 Reduced 7.28%	1,045 $240 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Abacus Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Abacus Wealth Partners, LLC with notifications on news.